In the unadjusted regression model, lower plasma adiponectin levels were significantly associated with nearly threefold and sixfold odds of either hepatic steatosis alone or NAFLD with coexisting significant fibrosis. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.